Transposon mutagenesis libraries reveal novel molecular requirements during CRISPR RNA-guided DNA integration.
Matt W G WalkerSanne E KlompeDennis J ZhangSamuel H SternbergPublished in: bioRxiv : the preprint server for biology (2023)
CRISPR-associated transposons (CASTs) direct DNA integration downstream of target sites using the RNA-guided DNA binding activity of nuclease-deficient CRISPR-Cas systems. Transposition relies on several key protein-protein and protein-DNA interactions, but little is known about the explicit sequence requirements governing efficient transposon DNA integration activity. Here, we exploit pooled library screening and high-throughput sequencing to reveal novel sequence determinants during transposition by the Type I-F Vibrio cholerae CAST system. On the donor DNA, large mutagenic libraries identified core binding sites recognized by the TnsB transposase, as well as an additional conserved region that encoded a consensus binding site for integration host factor (IHF). Remarkably, we found that VchCAST requires IHF for efficient transposition, thus revealing a novel cellular factor involved in CRISPR-associated transpososome assembly. On the target DNA, we uncovered preferred sequence motifs at the integration site that explained previously observed heterogeneity with single-base pair resolution. Finally, we exploited our library data to design modified transposon variants that enable in-frame protein tagging. Collectively, our results provide new clues about the assembly and architecture of the paired-end complex formed between TnsB and the transposon DNA, and inform the design of custom payload sequences for genome engineering applications of CAST systems.
Keyphrases
- crispr cas
- circulating tumor
- single molecule
- cell free
- genome editing
- genome wide
- protein protein
- nucleic acid
- dna binding
- gene expression
- small molecule
- randomized controlled trial
- circulating tumor cells
- clinical trial
- big data
- artificial intelligence
- clinical practice
- open label
- genetic diversity
- placebo controlled